Frequency and Determining Factors of Empiric Chemotherapy Dose Reduction in Patients with Non-Small Cell Lung Cancer
Journal Title: International Journal of Cancer Studies & Research (IJCR) - Year 2017, Vol 6, Issue 1
Abstract
Objectives: To determine the frequency and key factors regarding empiric chemotherapy dose reductions (ECDR) in nonsmall cell lung cancer (NSCLC) patients. Methods: This retrospective study involved the chart review of all histologically confirmed NSCLC patients receiving chemotherapy at the Odette Cancer Centre, Sunnybrook Health Sciences Complex, from 2013-2014. The frequency of ECDR and potential impacting factors were recorded and analyzed on SPSS v16.0. Results were expressed in percentages, P-values, and Cramer’s V. Results: Our findings (N = 134) suggested patients with moderate kidney disease stages were statistically associated with ECDR (29% vs. 24% vs. 50% for stage I, II, and III respectively, p = 0.031, φc = 0.235, df = 2). Patients aged 61 and above (39% vs. 14%, P = 0.001, φc = 0.23, df = 1), polypharmacy of 4 or more medications (24% vs. 44%, p = 0.017, φc = 0.21, df = 1), presence of kidney disease (43% vs. 24%, P = 0.024, φc = 0.20, df = 1), and palliative intent (40% vs. 12%, p = 0.0027, φc = 0.26, df = 1) showed statistically significant, but weak association with ECDR. Combinations (3 or more) of the impacting factors as mentioned above showed statistically significant association with ECDR (75% vs 42%, P = 0.00, φc = 0.308). The degree of ECDR were positively correlated to patient age, moderate stage chronic kidney disease, and having combinations of impacting factors. Conclusions and Relevance: ECDR was common in the NSCLC patients (33%), particularly in the elderly, polypharmacy, palliative care and kidney disease population. Variances might exist among physicians, which might lead to clinically significant outcomes. Guidance and future studies for ECDR is crucial especially as Ontario's senior population grows.
Authors and Affiliations
Chris Wong
Assessment of Treatment Compliance and Associated factors among Cervical Cancer Patients in Tikur Anbessa specialized hospital, Oncology unit, Ethiopia 2012
Background: Cervical cancer is a major public health problem through-out the world, and despite important declines in incidence and mortality observed in developed countries in the last 20 years, those indicators remain...
Factors Affecting Utilization of Cervical Cancer Screening Services among Nurses in a Teaching Hospital in Ibadan, Nigeria
Invasive cervical cancer is the second-most common cancer in women world-wide, 80% of these cases were discovered through records to be from developing countries. It can be readily detected in the premalignant phase, cer...
Assessment of fatigue in cancer patients
During the last decade, there has been a growing recognition of the high prevalence of fatigue among cancer patients, its adverse effect on their quality of life, and the need to develop effective interventions to preve...
Patient-Centered Outcomes Research In Advanced Stage Lung Cancer: Study Design and Population
Background: In 2013, researchers at the University of Nebraska Medical Center (UNMC) received funding from the Patient-Centered Outcomes Research Institute to establish a study that outlines treatment options for patient...
Stochastic Mathematical Models of Carcinogenesis
Geneticists and molecular biologists have demonstrated that carcinogenesis is a stochastic multi-stage process with each cancer tumor being derived from a single stem cell which has sustained a finite number of genetic a...